Summit Creek Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $7.44M | Sell |
|
|||||
|
2020
Q3 | $7.53M | Sell |
|
|||||
|
2020
Q2 | $9.67M | Buy |
|
|||||
|
2020
Q1 | $5.13M | Sell |
|
|||||
|
2019
Q4 | $7.4M | Sell |
|
|||||
|
2019
Q3 | $7.1M | Buy |
|
|||||
|
2019
Q2 | $7.85M | Buy |
|
|||||
|
2019
Q1 | $5.98M | Sell |
|
|||||
|
2018
Q4 | $6.47M | Buy |
|
|||||
|
2018
Q3 | $7.71M | Sell |
|
|||||
|
2018
Q2 | $10.4M | Sell |
|
|||||
|
2018
Q1 | $9.1M | Buy |
|
|||||
|
2017
Q4 | $5.83M | Sell |
|
|||||
|
2017
Q3 | $5.84M | Sell |
|
|||||
|
2017
Q2 | $5.25M | Sell |
|
|||||
|
2017
Q1 | $4.95M | Sell |
|
|||||
|
2016
Q4 | $6.26M | Sell |
|
|||||
|
2016
Q3 | $15.3M | Buy |
|
|||||
|
2016
Q2 | $14.1M | Sell |
|
|||||
|
2016
Q1 | $13.5M | Buy |
|
|||||
|
2015
Q4 | $8.68M | Buy |
|
|||||
|
2015
Q3 | $6.05M | Buy |
|